Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. E. Dankert-Roelse (Heerlen, Netherlands). 1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes". Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma

Member's Comments

No comment yet.

Related content which might interest you: Newborn screening and carrier screening for cystic fibrosis: alternative or complementary? Source: Eur Respir J 2014; 43: 20-23 Year: 2004 Is newborn screening for cystic fibrosis cost-effective? Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010 Newborn screening in Europe Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Newborn screening for cystic fibrosis - lessons from national programmes in Europe Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 Should the D1152H variant be included in cystic fibrosis newborn screening programmes? Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Newborn screening for cystic fibrosis: opportunities and remaining challenges Source: Eur Respir Monogr 2014; 64: 65-76 Year: 2014 Regular routine SF6 multiple breath washout in infants with cystic fibrosis born after implementation of neonatal screening Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Newborn screening for cystic fibrosis improves lung function and growth at time of transfer to adult care Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease Year: 2011 Early diagnosis from newborn screening maximises survival in severe cystic fibrosis Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017 Year: 2018 Early intervention studies in infants and preschool children with cystic fibrosis: are we ready? Source: Eur Respir J 2013; 42: 527-538 Year: 2013 Newborn cystic fibrosis (CF) screening: influence of data transformation and density estimation on newborn recall Source: Eur Respir J 2007; 30: Suppl. 51, 30s Year: 2007 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Newborn screening for cystic fibrosis in Spain Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Need for early intervention in cystic fibrosis - impact of an educational programme Source: Eur Respir J 2005; 26: Suppl. 49, 621s Year: 2005 Impact of developing an outreach educational programme for improving on the physician's ability to make the diagnosis of cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 124s Year: 2001